
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Protest inspired by 'Gen Z' movement draws few young people in Mexico and many government critics - 2
The most effective method to Pick the Right Material Organization: Your Definitive Aide - 3
The race is on to turn your body into a GLP-1 factory - 4
Journalists killed by Israeli strike in southern Lebanon - 5
Instructions to Improve Your Mental Exploration with Cutting edge Measurements
Spain and Catholic Church agree to compensate sex abuse victims
NASA's Artemis 2 pilot Victor Glover listens to 'Whitey on the Moon' every Monday. This is why.
Beyond the habitable zone: Exoplanet atmospheres are the next clue to finding life on planets orbiting distant stars
Iranian-linked drone attack kills Kurdish couple in northern Iraq
Sound Maturing: Wellbeing Tips for Each Life Stage
Figure out How to Explore the Infotainment Framework in the Slam 1500.
As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
This cafe takes orders in sign language. It's cherished by the Deaf community
Turning into a Distributed Writer: My Composing Process













